ASCO is joining with four other cancer organizations this week for a collaborative cancer research advocacy day on Capitol Hill. During the May 17 Hil...

[Read the rest of this article...]

Reps. Allyson Schwartz (D-Pa.) and Jo Heck (R-Nev.) introduced legislation in the House that would permanently repeal Medicare’s Sustainable Growth Rate formula and replace it with a new system of payment models. The Medicare Physician Payment Innovation Act also provides immediate relief from cuts of over 30 percent to physician reimbursements, scheduled to take place January 1, 2013.

[Read the rest of this article...]

ASCO has submitted comments in response to the Centers for Medicare and Medicaid Services’ proposed rule for Stage 2 of the EHR Meaningful Use I...

[Read the rest of this article...]

DOXIL® C.A.R.E.S. Physician Access Program will reopen enrollment to new patients on Friday, May 11 at noon EDT. Janssen Products, LP, the manufac...

[Read the rest of this article...]

Why are some networks of community oncology practices and hospitals more successful in enrolling patients on clinical trials than others? To try to answer that question, researchers from the University of North Carolina at Chapel Hill and the National Cancer Institute examined the design features of networks that in 2010 were consistently associated with high levels of enrollment onto National Cancer Institute cancer treatment trials.

[Read the rest of this article...]

ASCO and the Center for Medicare and Medicaid Services are requesting feedback from oncologists in Iowa, Kansas, Missouri and Nebraska on quality and ...

[Read the rest of this article...]

Senator Daniel Akaka (D-Hawaii), along with Senator Daniel Inouye (D-Hawaii), recently introduced, the Health Equity and Accountability Act (S. 2474) that focuses on improving the health of underserved minority communities.

[Read the rest of this article...]

Dr. Christine Chung, MD, a member of ASCO’s Cancer Research Committee, testified on behalf of ASCO at a Food and Drug Administration public hearing on “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice,” held April 23 at the FDA White Oak Campus in Silver Spring, Md.

[Read the rest of this article...]